Abeprazan (DWP14012) hydrochloride 是一种钾竞争性酸阻滞剂，通过钾竞争性离子结合可逆性抑制 H+,K+-ATPase，无需酸激活。

Omeprazole sulfide is an inhibitor of proton pump, it is the metabolite of omeprazole.

(R)-Lansoprazole, the dextrorotatory enantiomer of lansoprazole, can irreversibly inactivate the H+/K+-stimulated ATPase pump.

Lansoprazole sulfone (AG-1813)是一种口服活性和选择性的 H+, K+-ATPase 抑制剂，通过抑制 H+, K+-ATPase 显著刺激胃酸分泌，潜在用于治疗十二指肠溃疡、胃溃疡、胃食管反流病和佐林格-艾利森综合症。

Pumaprazole is a reversible proton pump antagonist.

Pantoprazole sodium is an inhibitor of proton pump that can suppress function of H+/K+ ATPase. It is used for the treatment of hyperacidity.

AZD0865 inhibits gastric H+,K+-ATPase by K+-competitive binding.

Tenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM.

SCH 28080 is an inhibitor of H+, K+-ATPase with IC50 of 20 nM.

Esomeprazole Magnesium Trihydrate can inhibit the H+/K+ ATPase and reduce acid secretion of gastric parietal cells.

Rabeprazole sodium is an inhibitor of proton pump with antiulcer activities.

Lansoprazole is an inhibitor of proton-pump. It can reduce the gastric acid production of stomach.

Esomeprazole sodium, the sodium salt of esomeprazole which has the effect of reducing gastric acid secretion.

Omeprazole is an inhibitor of proton pump with IC50 of 1.1 μM which can be used to treat dyspepsia.

Ilaprazole inhibited TOPK activities with high affinity and selectivity.

Esomeprazole magnesium is a proton pump inhibitor for the treatment of gastric acid secretion.